In compliance with paragraphs 3.63 to 3.74 of the JSE Listings Requirements, the following information is disclosed:
DEALING IN SECURITIES BY PRESCRIBED OFFICERS: DEFERRED SHARE AWARDS
Johannesburg. 2 March 2020. In line with the provisions of the 2018 Harmony Deferred Share Plan, shares are awarded to directors and prescribed officers in September of each year. The awards were made on the 18th of September 2019 based on the 5-day volume weighted average price of R46.89 per ordinary share. At the time, the directors and prescribed officers were subject to a closed period and were only allowed to accept the allocated shares awarded once the closed period was lifted on 14 February 2020.
The following transactions are disclosed in relation to deferred share awards:
| 1. Name of prescribed officer: | J van Heerden |
| Nature of transaction: | Off market acceptance of deferred shares |
| Periods of vesting: | Deferred shares vest in equal tranches over a five year period. |
| Date of acceptance of award: | 28 February 2020 |
| Class of securities: | Deferred ordinary shares |
| Number of deferred shares awarded: | 61 566 |
| Nature and extent of Prescribed officer’s interest: | Direct beneficial |
| 2. Name of prescribed officer: | B Nel |
| Nature of transaction: | Off market acceptance of deferred shares |
| Periods of vesting: | Deferred shares vest in equal tranches over a five year period. |
| Date of acceptance of award: | 28 February 2020 |
| Class of securities: | Deferred ordinary shares |
| Number of deferred shares awarded: | 32 976 |
| Nature and extent of prescribed officer’s interest: | Direct beneficial |
| 3. Name of prescribed officer: | VP Tobias |
| Nature of transaction: | Off market acceptance of deferred shares |
| Periods of vesting: | Deferred shares vest in equal tranches over a five year period. |
| Date of acceptance of award: | 28 February 2020 |
| Class of securities: | Deferred ordinary shares |
| Number of deferred shares awarded: | 38 714 |
| Nature and extent of prescribed officer’s interest: | Direct beneficial |
Prior clearance was obtained in respect of the above dealings by the directors.
For more details contact:
Marian van der Walt
Executive: Investor Relations
+27(0)82 888 1242 (mobile)
Johannesburg, South Africa
2 March 2020
Sponsor:
J.P. Morgan Equities South Africa Proprietary Limited